Shepherd Kaplan Krochuk, LLC Checkpoint Therapeutics, Inc. Transaction History

Shepherd Kaplan Krochuk, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$2.15 - $3.36 $21,500 - $33,600	-10,000 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$2.75 - $5.0 $110,000 - $200,000	-40,000 Reduced 80.0%	10,000 $30,000
Q4 2018 Feb 12, 2019	BUY	$1.54 - $3.35 $15,400 - $33,500	10,000 Added 25.0%	50,000 $91,000
Q3 2018 Nov 14, 2018	BUY	$2.46 - $4.72 $98,400 - $188,800	40,000 New	40,000 $143,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $297M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Shepherd Kaplan Krochuk, LLC, based on Form 13F filings with the SEC.

Stay updated on Shepherd Kaplan Krochuk, LLC with notifications on news.